Drug Profile
Research programme: DP 71 - D-Pharm
Alternative Names: DP-71Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator D-Pharm
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Psoriasis
- Discontinued Brain cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Psoriasis in Israel (Topical)
- 08 Sep 2010 This programme is still in active development for psoriasis
- 27 Sep 2006 Discontinued - Preclinical for Brain cancer in Israel (Injection)